Eveglim-M 2 Tablet SR is a combination oral antidiabetic medication containing Glimepiride 2mg and Metformin 500mg, designed for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class drug, works by stimulating pancreatic beta cells to release insulin, thereby reducing blood glucose levels. Metformin, a biguanide, improves insulin sensitivity and decreases hepatic glucose production, contributing to better glycemic control. The sustained-release (SR) formulation ensures a gradual release of the active ingredients, promoting stable blood sugar levels throughout the day and enhancing patient compliance by reducing dosing frequency. Eveglim-M 2 Tablet SR is typically prescribed when diet, exercise, and monotherapy with either agent alone do not achieve adequate glycemic control. It is important to use this medication under medical supervision, as improper use may lead to hypoglycemia or gastrointestinal side effects such as nausea, diarrhea, or abdominal discomfort. Regular monitoring of blood glucose and renal function is recommended during treatment. This combination therapy offers a synergistic approach to managing type 2 diabetes, helping patients maintain optimal blood sugar levels and reduce the risk of diabetes-related complications.

Dosage & How to Use